Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/857171/000091412105002163/ab86022-ex99_1.txt
July 2006
March 2006
October 2005
August 2005
July 2005
July 2005
July 2005
July 2005
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/857171/000091412105002163/ab86022-ex99_1.txt
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Able Laboratories Inc.
Able Laboratories Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2005 10-K Annual Report includes:
CIK: 857171Events:
Form Type: 8-K Corporate News
Accession Number: 0000914121-05-002163
Submitted to the SEC: Thu Nov 17 2005 4:40:39 PM EST
Accepted by the SEC: Thu Nov 17 2005
Period: Friday, November 11, 2005
Industry: In Vitro And In Vivo Diagnostic Substances